Malignant Endometrial Neoplasm — Trials

Malignant Endometrial Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,198 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 359
Recruiting: 203
Ph III recruiting: 21
Growth YoY: +3.8%
Industry share: 33%
Top sponsor: National Cancer Institute (NCI)
Termination share: 28.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (112)

clinicaltrialsPublishedShowing 101–150 of 269 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06906341	Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers	recruiting	Phase 2	270	Corcept TherapeuticsINDUSTRY	8	Jul 16, 2026	clinicaltrials
NCT07209449	A Study of Elacestrant Alone or in Combination With Abemaciclib in People With Endometrial Cancer	recruiting	Phase 2	75	Memorial Sloan Kettering Cancer CenterOTHER	1	Jul 16, 2026	clinicaltrials